Advertisement
Singapore markets close in 43 minutes

  • Straits Times Index

    3,192.75
    +38.06 (+1.21%)
     

  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     

  • Hang Seng

    16,410.47
    +158.63 (+0.98%)
     

  • FTSE 100

    7,895.13
    +47.14 (+0.60%)
     

  • Bitcoin USD

    60,998.63
    -2,487.26 (-3.92%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • Dow

    37,753.31
    -45.66 (-0.12%)
     

  • Nasdaq

    15,683.37
    -181.88 (-1.15%)
     

  • Gold

    2,393.90
    +5.50 (+0.23%)
     

  • Crude Oil

    81.97
    -0.72 (-0.87%)
     

  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     

  • FTSE Bursa Malaysia

    1,546.46
    +6.04 (+0.39%)
     

  • Jakarta Composite Index

    7,172.42
    +41.58 (+0.58%)
     

  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

Factbox - Leaders in U.S. neurotechnology patents

Reuters

(Reuters) - Leaders in neurotechnology, which ranges from noninvasive systems that use magnetic stimulation to treat depression to devices that let gamers control avatars with only their thoughts, include some expected medical-device companies but also several surprises, according to an analysis by market-research firm SharpBrains. Its "IP Strength Index" reflects the number of patents as well as their breadth and influence:

Patents holder IP Strength Index

1. The Nielsen Company 100

2. Advance Neuromodulation Systems 99

(St. Jude Medical Inc.)

3. Medtronic PLC 98

4. Microsoft Corp. 89

5. Brainlab 76

6. Posit Science 76

7. BodyMedia 73

(Jawbone)

8. Neuronetics 72

9. NeuroPace 72

10. Accenture PLC 72

11. General Electric Co. 72

(Reporting by Sharon Begley; editing by Andrew Hay)